Strychnine inhibits inflammatory angiogenesis in mice via down regulation of VEGF, TNF-α and TGF-β

Microvascular Research

Volumn 87, Issue , 2013, Pages 7-13

  Saraswati, Sarita ^a   Agarwal, S S ^b  

^a DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^b AMITY UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; COLLAGEN; HEMOGLOBIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; POLYESTER; POLYURETHAN; STRYCHNINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG DOSE COMPARISON; EXTRACELLULAR MATRIX; GRANULOMA; IMPLANT; MACROPHAGE; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ACETYLGLUCOSAMINIDASE; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EXTRACELLULAR MATRIX; HEMOGLOBINS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PEROXIDASE; POLYESTERS; POLYURETHANES; STRYCHNINE; SURGICAL SPONGES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS; STRYCHNOS TOXIFERA;

EID: 84876335650     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.01.003     Document Type: Article

References (39)

1. Andrade S.P., Fan T.P.D., Lewis G.P. Quantitative in vivo studies on angiogenesis in rat sponge model. Br. J. Exp. Pathol. 1987, 68:755-756.
2. Andrade S.P., Bakhle Y.S., Hart I., Piper P.J. Effects of tumor cells and vasoconstrictor responses in sponge implants in mice. Br. J. Cancer 1992, 66:821-826.
3. Appleton I., Brown N.J., Willis D., et al. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J. Pathol. 1996, 180:90-94.
4. Barcelos L.S., Coelho A.M., Russo R.C., et al. Role of the chemokines. CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc. Res. 2009, 78:148-154.
5. Belo A.V., Barcelos L.S., Ferreira M.A.N.D., Teixeira M.M., Andrade S.P. Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice. Life Sci. 2004, 74:2827-2837.
6. Bergheim I., Luyendyk J.P., Steele C., et al. Metformin prevents endotoxin induced liver injury after partial hepatectomy. J. Pharmacol. Exp. Ther. 2006, 316:1053-1061.
7. Bonanno E., Iurlaro M., Madri J.A., et al. Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell. Dev. Biol. Anim. 2000, 36:336-340.
8. Campos P.P., Bakhle Y.S., Andrade S.P. Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain. Wound Repair Regen. 2008, 16:416-424.
9. Chen H.X., Gore-Langton R.E., Cheson B.D. Clinical trials referral resource: current clinical trials of the anti-VEGF monoclonal antibody bevacizumab. Oncology 2001, 15:1023-1026.
10. Colotta F., Allavena P., Sica A., et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
11. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 2003, 3:921-930.
12. Connolly D., Olander J., Heuvelman D., N., et al. Human vascular permeability factor. Isolation from U937 cells. J. Biol. Chem. 1989, 264:20017-20024.
13. Deng X.K., Yin W., Li W.D., Yin F.Z., Lu X.Y., Zang X.C., Hua Z.C., Cai B.C. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J. Ethnopharmacol. 2006, 106:179-186.
14. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 2002, 21:4368-4380.
15. Edward R.H., Sarmenta S.S., Hass G.M. Stimulation of granulation tissue growth by tissue extracts; study by intramuscular wounds in rabbits. Arch. Pathol. 1960, 69:286-02.
16. Ferreira M.A., Barcelos L.S., Teixeira M.M., Bakhle Y.S., Andrade S.P. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). Life Sci. 2007, 81:210-217.
17. Hanahan D., Weinber R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
18. Hlkatky L., Hahnfeldt P., Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J. Natl. Cancer Inst. 2002, 94:883-893.
19. Holderfield M.T., Hughes C.C. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ. Res. 2008, 102:637-652.
20. Huijbers I.J., Iravani M., Popov S., et al. A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One 2010, 5:e9808.
21. Kauppila S., Stenbäck F., Risteli J., et al. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J. Pathol. 1998, 186:262-268.
22. Lage A.P., Andrade S.P. Assessment of angiogenesis and tumor growth in conscious mice by a fluorimetric method. Microvasc. Res. 2000, 59:278-285.
23. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
24. Levental K.R., Yu H., Kass L., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
25. Mendes J.B., Rocha M.A., Araújo F.A., et al. Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. Microvasc. Res. 2009, 78:265-271.
26. Nicosia R.F., Nicosia S.V., Smith M. Vascular endothelial growth factor, platelet-derived growth factor and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol. 1994, 145:1023-1029.
27. Passaniti A., Taylor A.M., Pili R., Guo Y., Long P.V., Haney J.A., Pauly R.R., Grant D.S., Martin G.R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 1992, 67:519-528.
28. Philippe G., Angenot L., Tits M., Frederich M. About the toxicity of some Strychnos species and their alkaloids. Toxicon 2004, 44:405-416.
29. Phillips G.D., Stone A.M., Jones B.D., et al. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo 1995, 8:961-965.
30. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004, 114:438-446.
31. Plouet J., Schilling J., Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J. 1989, 8:3801-3806.
32. Saraswati S., Pandey M., Mathur R., Agrawal S.S. Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model. Microvasc. Res. 2011, 82:263-268.
33. Tolentino M.J., Miller J.W., Gragoudas E.S., et al. VEGF is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate. Arch. Ophthalmol. 1996, 114:964-970.
34. Tripathi Y.B. Free radicals in Ayurveda. Anc. Sci. Life 1998, 17:158-168.
35. Tripathi Y.B., Chaurasia S. Interaction of Strychnos nux-vomica products and iron: with reference to lipid peroxidation. Phytomedicine 2000, 7:523-528.
36. Yamaoka M., Masaki T., Sudo K., Shino A., Fujita T. Acceleration of wound healing by recombinant human basic fibroblast growth factor in a rat sponge-implantation model. Jpn. J. Inflamm. 1991, 11:65-72.
37. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-249.
38. Yin W., Wang T.S., Yin F.Z., Cai B.C. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnox nux-vomica. J. Ethnopharmacol. 2003, 88:205-214.
39. Zhu G.G., Risteli L., Mäkinen M., et al. Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer 1995, 75:1010-1017.